Statement Of Income

Chiome Bioscience Inc. - Filing #7550870

Concept 2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
Statement of income
Statement of income
Net sales
Net sales
358,889,000 JPY
358,889,000 JPY
358,889,000 JPY
JPY
JPY
278,211,000 JPY
JPY
JPY
278,211,000 JPY
278,211,000 JPY
Operating revenue
Cost of sales
Cost of sales
150,211,000 JPY
127,082,000 JPY
Operating expenses
Selling, general and administrative expenses
867,926,000 JPY
930,345,000 JPY
Other
266,026,000 JPY
239,364,000 JPY
Operating expenses
Research and development expenses
601,900,000 JPY
690,981,000 JPY
Operating profit (loss)
208,677,000 JPY
-393,223,000 JPY
-659,249,000 JPY
-266,026,000 JPY
-601,900,000 JPY
-539,851,000 JPY
-239,364,000 JPY
-690,981,000 JPY
151,129,000 JPY
-779,216,000 JPY
Gross profit (loss)
208,677,000 JPY
151,129,000 JPY
Non-operating income
Interest income
10,000 JPY
11,000 JPY
Gross profit
Ordinary profit (loss)
-662,139,000 JPY
-768,686,000 JPY
Non-operating income
424,000 JPY
16,216,000 JPY
Financial revenue
Extraordinary income
1,003,000 JPY
186,000 JPY
Non-operating expenses
Interest expenses
910,000 JPY
645,000 JPY
Non-operating expenses
Non-operating income
Other
414,000 JPY
205,000 JPY
Selling, general and administrative expenses
Extraordinary losses
14,000 JPY
JPY
Non-operating expenses
Non-operating expenses
3,314,000 JPY
5,687,000 JPY
Financial expenses
Share issuance costs
940,000 JPY
1,416,000 JPY
Other
0 JPY
286,000 JPY
Extraordinary income
Gain on sale of non-current assets
73,000 JPY
JPY
Profit (loss) before income taxes
-661,150,000 JPY
-768,500,000 JPY
Extraordinary losses
Loss on sale of non-current assets
14,000 JPY
JPY
Income taxes - current
2,505,000 JPY
2,505,000 JPY
Income taxes
2,505,000 JPY
2,505,000 JPY
Profit (loss)
-663,655,000 JPY
-771,005,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.